Rejoyn | search
Click here to view Rejoyn news from 60+ newspapers.
Bookmark or Share- You Can Now Treat Depression With an App | TIMEThe app, called Rejoyn, is cleared as a supplement to currently approved therapies and works by using specifically designed tasks on a smartphone app to rewire neural signals. The idea is to tap ...
- Rejoyn: First App Cleared by FDA for Depression; Cost, Efficacy UnclearA novel smartphone-delivered treatment, Rejoyn, has become the first app to gain clearance from the Food and Drug Administration for the treatment of major depressive disorder (MDD), and is expected to be available for patient downloads starting this summer.
- Rejoyn: First and only prescription app for MDD symptomsINDICATION: Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication. It is intended to reduce MDD symptoms.
- FDA clears first digital treatment for depression, but experts ... - CNNRejoyn is a smartphone app intended for use alongside antidepressant medications for people 22 and older who have a diagnosis of major depressive disorder. The US Food and Drug Administration is...
- Rejoyn: An add-on prescription app for depression symptomsINDICATION: Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication. It is intended to reduce MDD symptoms.
More
